Strs Ohio Regenxbio Inc. Transaction History

Strs Ohio

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$22.29 - $35.04 $33,435 - $52,560	-1,500 Reduced 4.78%	29,900 $790,000
Q2 2022 Jul 25, 2022	BUY	$19.35 - $35.04 $268,965 - $487,056	13,900 Added 79.43%	31,400 $775,000
Q1 2022 Apr 21, 2022	BUY	$24.62 - $34.31 $275,744 - $384,272	11,200 Added 177.78%	17,500 $580,000
Q3 2021 Oct 22, 2021	BUY	$29.09 - $45.68 $26,181 - $41,112	900 Added 16.67%	6,300 $264,000
Q2 2021 Jul 26, 2021	BUY	$32.46 - $40.48 $175,284 - $218,591	5,400 New	5,400 $209,000

Q3 2019 Oct 21, 2019	SELL	$31.84 - $50.88 $573,120 - $915,840	-18,000 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$40.82 - $62.45 $57,148 - $87,430	-1,400 Reduced 7.22%	18,000 $1.03 Million
Q4 2018 Jan 23, 2019	BUY	$39.11 - $75.15 $109,508 - $210,420	2,800 Added 16.87%	19,400 $813,000
Q3 2018 Oct 19, 2018	SELL	$65.0 - $82.15 $143,000 - $180,730	-2,200 Reduced 11.7%	16,600 $1.25 Million
Q2 2018 Aug 06, 2018	BUY	$27.2 - $74.35 $125,120 - $342,010	4,600 Added 32.39%	18,800 $1.35 Million
Q1 2018 Apr 20, 2018	SELL	$24.05 - $37.5 $202,020 - $315,000	-8,400 Reduced 37.17%	14,200 $423,000
Q4 2017 Jan 23, 2018	SELL	$26.0 - $34.6 $15,600 - $20,760	-600 Reduced 2.59%	22,600 $751,000
Q3 2017 Oct 23, 2017	BUY	$18.0 - $32.95 $417,600 - $764,440	23,200	23,200 $764,000

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.